Anxiety Disorders in Patients With Somatic Diseases

被引:20
作者
Henning, Michaela [1 ,2 ]
Subic-Wrana, Claudia [1 ]
Wiltink, Joerg [1 ]
Beutel, Manfred [1 ]
机构
[1] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany
[2] Univ Cologne, Univ Hosp Cologne, Dept Psychosomat & Psychotherapy, Cologne, Germany
来源
PSYCHOSOMATIC MEDICINE | 2020年 / 82卷 / 03期
关键词
anxiety disorders; comorbidity; inpatient treatment; effectiveness; cardiac disease; diabetes mellitus; COPD; arthritis; CBT = cognitive behavioral therapy; CHD = coronary heart disease; COPD = chronic obstructive pulmonary disease; GAD = generalized anxiety disorder; MI = myocardial infarction; PTSD = posttraumatic stress disorder; RCT = randomized controlled trial; CORONARY-ARTERY-DISEASE; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; PANIC DISORDER; HEART-DISEASE; RHEUMATOID-ARTHRITIS; DEPRESSIVE-DISORDERS; HOSPITAL TREATMENT; GLYCEMIC CONTROL; SOCIAL PHOBIA;
D O I
10.1097/PSY.0000000000000779
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective Anxiety disorders are among the most frequent mental disorders and are associated with a range of short- and long-term impairments and disabilities. Relatively little is known about anxiety disorders in patients with somatic diseases, and the present literature review highlights the current research in this field, data about prevalences of anxiety disorders in patients with somatic diseases, and the effectiveness of interventions. This article also introduces a comprehensive model of inpatient treatment and summarizes the evidence pertinent to this approach. Methods A narrative review is presented with regard to prevalence and treatment of anxiety disorders in patients with somatic diseases. The effects of inpatient treatment are illustrated based on a case report. Results This review indicates that anxiety disorders are more common in patients with somatic diseases, with prevalence estimates ranging from 2.5% to 55%, than in the general population. Several outpatient treatment options exist, with substantial support for the effectiveness of cognitive behavioral therapy, psychodynamic therapy, and pharmacotherapy. We also provide evidence in support of psychosomatic inpatient treatment for patients with anxiety disorders that are comorbid with somatic diseases. Conclusions Anxiety disorders are common in patients with somatic diseases, and several effective treatment options exist, including cognitive behavioral therapy and pharmacological interventions. We also provide support for the effectiveness of inpatient treatment with unique opportunities for multidisciplinary psychosomatic treatment of anxiety disorders with comorbid somatic diseases.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 71 条
[61]   Mindfulness-based cognitive therapy for people with diabetes and emotional problems: Long-term follow-up findings from the DiaMind randomized controlled trial [J].
van Son, Jenny ;
Nyklicek, Ivan ;
Pop, Victor J. ;
Blonk, Marion C. ;
Erdtsieck, Ronald J. ;
Pouwer, Francois .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2014, 77 (01) :81-84
[62]   The association between arthritis and psychiatric disorders; results from a longitudinal population-based study [J].
van't Land, Hedda ;
Verdurmen, Jacqueline ;
ten Have, Margreet ;
van Dorsselaer, Saskia ;
Beekman, Aartjan ;
de Graaf, Ron .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2010, 68 (02) :187-193
[63]   The effect of exercise therapy on depressive and anxious symptoms in patients with ischemic heart disease: A systematic review [J].
Verschueren, Suzanne ;
Eskes, Anne M. ;
Maaskant, Jolanda M. ;
Roest, Annelieke M. ;
Latour, Corine H. M. ;
Reimer, Wilma Scholte Op .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2018, 105 :80-91
[64]   Depression- and anxiety-related sick leave and the risk of permanent disability and mortality in the working population in Germany: a cohort study [J].
Wedegaertner, Felix ;
Arnhold-Kerri, Sonja ;
Sittaro, Nicola-Alexander ;
Bleich, Stefan ;
Geyer, Siegfried ;
Lee, William E. .
BMC PUBLIC HEALTH, 2013, 13
[65]   Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: The Fremantle Diabetes Study Phase II [J].
Whitworth, S. R. ;
Bruce, D. G. ;
Starkstein, S. E. ;
Davis, W. A. ;
Davis, T. M. E. ;
Bucks, R. S. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 122 :190-197
[66]   Anxiety Disorders in Patients With COPD: A Systematic Review [J].
Willgoss, Thomas George ;
Yohannes, Abebaw Mengistu .
RESPIRATORY CARE, 2013, 58 (05) :858-866
[67]   Prevalence of distress, comorbid conditions and well being in the general population [J].
Wiltink, Joerg ;
Beutel, Manfred E. ;
Till, Yvonne ;
Ojeda, Francisco M. ;
Wild, Philipp S. ;
Muenzel, Thomas ;
Blankenberg, Stefan ;
Michal, Matthias .
JOURNAL OF AFFECTIVE DISORDERS, 2011, 130 (03) :429-437
[68]   Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression [J].
Zafar, M. Urooj ;
Paz-Yepes, Manuel ;
Shimbo, Daichi ;
Vilahur, Gemma ;
Burg, Matthew M. ;
Chaplin, William ;
Fuster, Valentin ;
Davidson, Karina W. ;
Badimon, Juan J. .
EUROPEAN HEART JOURNAL, 2010, 31 (13) :1573-1582
[69]   Prognostic and prescriptive predictors of improvement in a naturalistic study on inpatient and day hospital treatment of depression [J].
Zeeck, Almut ;
von Wietersheim, Joern ;
Weiss, Heinz ;
Scheidt, Carl Eduard ;
Voelker, Alexander ;
Helesic, Astrid ;
Eckhardt-Henn, Annegret ;
Beutel, Manfred ;
Endorf, Katharina ;
Treiber, Franziska ;
Rochlitz, Peter ;
Hartmann, Armin .
JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 :205-214
[70]  
Zielke M, 1999, PSYCHOTHER PSYCH MED, V49, P361